These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12668487)

  • 21. Anaemia and renal dysfunction in chronic heart failure.
    van der Meer P; van Veldhuisen DJ
    Heart; 2009 Nov; 95(21):1808-12. PubMed ID: 19828825
    [No Abstract]   [Full Text] [Related]  

  • 22. Beta-blockers continue to surprise us.
    Cruickshank JM
    Eur Heart J; 2000 Mar; 21(5):354-64. PubMed ID: 10666349
    [No Abstract]   [Full Text] [Related]  

  • 23. Should beta-blockers form the cornerstone for the treatment of congestive heart failure?
    Tabrizchi R
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):157-60. PubMed ID: 15030275
    [No Abstract]   [Full Text] [Related]  

  • 24. Angiotensin-converting enzyme inhibitors, beta-blockers, and mortality in systolic heart failure.
    Thornton PL; Ahmed A
    J Am Coll Cardiol; 2004 Apr; 43(7):1333; author reply 1333-4. PubMed ID: 15063454
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical inquiries. What is the most effective beta-blocker for heart failure?
    Neher JO; Safranek S; Grover F
    J Fam Pract; 2003 May; 52(5):396, 398-9. PubMed ID: 12737773
    [No Abstract]   [Full Text] [Related]  

  • 26. Short-term improvement in submaximal exercise capacity by optimized therapy with ACE inhibitors and beta blockers in heart failure patients is associated with restoration of peripheral endothelial function.
    Poelzl G; Frick M; Lackner B; Huegel H; Alber HF; Mair J; Herold M; Schwarzacher SP; Pachinger O; Weidinger F
    Int J Cardiol; 2006 Mar; 108(1):48-54. PubMed ID: 16516697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug treatment of heart failure].
    Kettunen R
    Duodecim; 2005; 121(11):1239-48. PubMed ID: 15999983
    [No Abstract]   [Full Text] [Related]  

  • 28. Inadequate treatment of congestive heart failure in dialysis patients.
    Bouchard J; Madore F
    Semin Dial; 2007; 20(5):383-6. PubMed ID: 17897240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
    Thanikachalam S; Manchanda SC
    Indian Heart J; 2003; 55(2):167-71. PubMed ID: 12921333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
    G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chronic heart failure. Diagnosis and therapy].
    Schwinger RH
    Med Monatsschr Pharm; 2000 May; 23(5):142-8. PubMed ID: 10838829
    [No Abstract]   [Full Text] [Related]  

  • 32. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
    Le Jemtel TH; Padeletti M; Jelic S
    J Am Coll Cardiol; 2007 Jan; 49(2):171-80. PubMed ID: 17222727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
    Rapp JA; Gheorghiade M
    Heart Fail Clin; 2005 Apr; 1(1):77-93. PubMed ID: 17386836
    [No Abstract]   [Full Text] [Related]  

  • 34. Digitalis for treatment of congestive heart failure in patients in sinus rhythm.
    Cayley WE
    Am Fam Physician; 2004 Jan; 69(1):71-2. PubMed ID: 14727819
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of chronic heart failure in a managed care setting. Baseline results from the Achieving Cardiac Excellence Project.
    Schmedtje JF; Evans GW; Byerly W; King M; Goonan K; Blastock-Glenn C; Croft JB; Goff DC
    N C Med J; 2003; 64(1):4-10. PubMed ID: 12774552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
    Azadpour M; Lamas GA
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):891-902. PubMed ID: 15500434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time trends in the use of beta-blockers and other pharmacotherapies in older adults with congestive heart failure.
    Smith NL; Chan JD; Rea TD; Wiggins KL; Gottdiener JS; Lumley T; Psaty BM
    Am Heart J; 2004 Oct; 148(4):710-7. PubMed ID: 15459605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart failure patients with low blood pressure: how should we manage neurohormonal blocking drugs?
    Parwani P; Ryan J
    Circ Heart Fail; 2012 Nov; 5(6):819. PubMed ID: 23170021
    [No Abstract]   [Full Text] [Related]  

  • 39. [Administration of beta-blockers and ACE inhibitors in this indication is frequently limited by hypotensive cardiovascular parameters].
    Internist (Berl); 1996 Jul; 37(7):739-40. PubMed ID: 8766269
    [No Abstract]   [Full Text] [Related]  

  • 40. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.